ProMIS Neurosciences Initiates Phase 1b Clinical Trial (PRECISE-AD) in Alzheimer’s Disease
Go back to ProMIS Neurosciences Initiates Phase 1b Clinical Trial (PRECISE-AD) in Alzheimer’s Disease| Imperial Petroleum, Inc. (NASDAQ: PMN) | Delayed: 13.79 -0.2 (1.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.99 | 52 Week High | $0.05 | |||
| Open | $14.07 | 52 Week Low | $0.05 | |||
| Day High | $14.60 | P/E | N/A | |||
| Day Low | $13.47 | EPS | $0.00 | |||
| Volume | 51,475 | |||||
